Cytek Biosciences Inc
NASDAQ:CTKB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
E
|
Eli Lilly and Co
DUS:LLY
|
US |
|
E
|
Eli Lilly and Co
XMUN:LLY
|
US |
Intrinsic Value
The intrinsic value of Cytek Biosciences Inc (CTKB) under the Base Case is 4.954 USD per share.
Compared with the current market price of 5.795 USD, the stock appears
Overvalued by 15% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cytek Biosciences Does
Cytek Biosciences makes instruments and software used in flow cytometry, a lab method that analyzes cells by passing them in front of lasers and detectors. Its main products are cell-analyzing instruments, reagents, and data-analysis tools that help researchers and labs measure many properties of single cells at once. The company’s systems are used in life-science research, drug development, and clinical and translational labs that need detailed cell analysis.
- Headquarters
- United States of America US
- Employees
- 678
- IPO date
- Jul 23, 2021
Earnings Waterfall
Cytek Biosciences Inc
The intrinsic value for Cytek Biosciences Inc (CTKB) under the Base Case is 4.954 USD.
Compared with the current market price of 5.795 USD, the stock appears Overvalued by 15% .
